Found 28 matching trials
α-N-acetylgalactosaminidase in Schizoaffective Disorder
N/ASchizoaffective disorder (SAD) is a severe psychiatric condition characteri...
Location
Elazığ Mental Health and Diseases Hospital Psychiatry Clinic
Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia
NABackground: Antioxidants are substances that are considered as a defensive ...
STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia
NAThis project aims to provide the proof of concept for transcranial direct-c...
Location
Centre Hospitalier Le Vinatier - Service de Psychiatrie Adulte
Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders
NAThe microbiota plays a vital role in the two-way communication between the ...
Location
Universidad de Córdoba.
Upside Down, Give me the Handle
NAIn schizophrenia, dislocation of psychic functions involving a loss of cont...
Location
CHU de SAINT-ETIENNE
Coronary Artery Disease in Patients Suffering From Schizophrenia
NASchizophrenia is a severe mental illness associated with excess mortality a...
Location
Aalborg University Hospital, Psychiatric Hospital
Validating Reward-related Biomarkers (RTOC)
N/ADeficits or abnormalities in reward processing are present in a number of p...
Location
University Hospital Frankfurt, Department of Psychiatry, Psychosomatic Medicine and Psychotherap
Study on Communication Comprehension in the Schizophrenic Spectrum
NAThe purpose of the present study is to evaluate the effect of emotional pro...
Location
HDJ François Villon
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
NAPsychosis is a severe, common, and disabling psychological disorder. An epi...
Location
Dr Efflam BREGEON
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
NAThe aim of the current study is set out to find a human model for negative ...
Location
Bar-Ilan University